Modeling Huntington׳s disease with patient-derived neurons

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Huntington's Disease (HD) is a fatal neurodegenerative disorder linked to expanded polyglutamine repeats in the Huntingtin (HTT) gene.
• Current HD models using non-neuronal cells and rodents have limitations in fully recapitulating disease phenotypes and treatment responses.
• Understanding the specific toxicity of mutant HTT (mtHTT) to striatal medium spiny neurons (MSNs) remains a critical knowledge gap.

Purpose of the Study:

• To review advancements in modeling Huntington's Disease using human patient-derived neurons.
• To explore the potential of pluripotent stem cells for generating disease-specific neurons for in vitro and in vivo studies.
• To highlight challenges and controversies in developing optimal human neuron models for HD research.

Main Methods:

• Differentiation of human pluripotent stem cells (embryonic stem cells and induced pluripotent stem cells) into medium spiny neurons (MSNs).
• Generation of chimeric animals using human HD patient MSNs for in vivo disease modeling.
• Analysis of established phenotypes in cell-based models and transplantation studies.

Main Results:

• Human HD patient MSNs derived from pluripotent stem cells offer a more disease-relevant model compared to traditional methods.
• In vitro and in vivo models using these neurons demonstrate characteristic HD phenotypes.
• Transplantation studies provide insights into the behavior and integration of HD patient-derived neurons.

Conclusions:

• Human pluripotent stem cell-derived neurons represent a significant advancement for modeling Huntington's Disease.
• These models facilitate a deeper understanding of HD pathogenesis and the development of targeted therapies.
• Ongoing research is needed to address challenges regarding optimal cell lines, cell types, and the study of adult-onset diseases in developmental models.